新关注 > 信息聚合 > 辉瑞计划并购非高风险研发线资产

辉瑞计划并购非高风险研发线资产

Pfizer plans to M & a non high risk R & D line assets

2015-01-30 14:29:27来源: 丁香园

辉瑞是一家有意向交易的制药商,其坐拥数十亿美元的现金,该公司对收购接近上市的资产更感兴趣,而非投资长期项目,辉瑞期望进行重磅炸弹级肿瘤合作,以保持其早期研究发的持续发展。在与分析师的一个电话会议上,...

Pfizer is a transaction intention of pharmaceutical manufacturers, it is sitting on billions of dollars in cash, the company acquired close to the listing of assets more interested in, rather than invest in long-term projects, Pfizer expects of blockbuster Cancer Cooperative, to keep his early research of sustainable development. At a conference call with analysts,...